We are live on ! Find out more
NVAX icon

Novavax
NVAX

155 hedge funds and large institutions have $218M invested in Novavax in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 31

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

3% more funds holding

Funds holding: 151 → 155 (+4)

0.13% less ownership

Funds ownership: 2.26% → 2.13% (-0.13%)

8% less call options, than puts

Call options by funds: $2.08M | Put options by funds: $2.27M

33% less capital invested

Capital invested by funds: $327M → $218M (-$109M)

Holders
155
Holders Change
+4
Holders Change %
+2.65%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
66
Reduced
31
Closed
17
Calls
$2.08M
Puts
$2.27M
Net Calls
-$189K
Net Calls Change
-$950K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.66M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.4M
3
Morgan Stanley
Morgan Stanley
New York
+$6.08M
4
CH
CVI Holdings
Delaware
+$5.6M
5
Two Sigma Investments
Two Sigma Investments
New York
+$2.67M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$12.2M
2
Deutsche Bank
Deutsche Bank
Germany
-$7.58M
3
Millennium Management
Millennium Management
New York
-$6.13M
4
JP Morgan Chase
JP Morgan Chase
New York
-$4.26M
5
BBA
Baker Bros. Advisors
New York
-$4.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
MYIA
151
Mount Yale Investment Advisors
Colorado
$1K +$1.69K +50 New
MPWT
152
MassMutual Private Wealth & Trust
Connecticut
$902 – – –
Renaissance Technologies
153
Renaissance Technologies
New York
– -$12.2M -289,323 Closed
BBA
154
Baker Bros. Advisors
New York
– -$4.2M -100,000 Closed
EGI
155
EAM Global Investors
California
– -$1.02M -24,315 Closed
EI
156
EAM Investors
California
– -$905K -21,552 Closed
RA
157
Royce & Associates
New York
– -$819K -19,500 Closed
ECM
158
Element Capital Management
New York
– -$348K -8,276 Closed
Jane Street
159
Jane Street
New York
– -$331K -7,870 Closed
CG
160
Clinton Group
New York
– -$220K -5,237 Closed
SAM
161
Silphium Asset Management
United Kingdom
– -$124K -2,941 Closed
PHK
162
Point72 Hong Kong
Hong Kong
– -$35K -825 Closed
HF
163
HRT Financial
New York
– -$29K -712 Closed
GT
164
Glenmede Trust
Pennsylvania
– -$12K -500 Closed
CCA
165
Clearwater Capital Advisors
Illinois
– -$11K -250 Closed
SWP
166
Stratos Wealth Partners
Ohio
– -$5K -125 Closed
MAM
167
Meeder Asset Management
Ohio
– -$2K -53 Closed
APP
168
Avantax Planning Partners
Iowa
– -$1K -14 Closed
FIA
169
FNY Investment Advisers
New York
– +$845 +25 New
3 4 5 6
7

NVAX Hedge Fund Activity: Q2 2018 in Review

155 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2018, worth a combined $218M — down 33% from $327M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NVAX positions and 17 closed out — a net gain of 5 holders — while 66 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $9.66M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $12.2M sold.

  • 155 institutional investors held Novavax (NVAX) as of Q2 2018, up from 151 in Q1 2018.
  • Funds reported $218M of Novavax stock for Q2 2018, down 33% quarter-over-quarter.
  • 22 funds opened new Novavax positions in Q2 2018 and 17 closed out, a net change of +5 holders.
  • The largest Novavax buyer in Q2 2018 was BlackRock, an estimated $9.66M added.
  • The largest Novavax seller in Q2 2018 was Renaissance Technologies, an estimated $12.2M sold.

Based on aggregated 13F filings for Q2 2018.